J. Ma, “1 Clinical Efficacy and Serum Inflammatory Factor Level (serum IFCs, bone Gla protein (BGP), and bone turnover markers β-collagen degradation product (β-CTX), and procollagen type 1 N-terminal propeptide (P1NP) )Changes of Zoledronic Acid and Denosumab in T: serum IFCs, bone Gla protein (BGP), and bone turnover markers β-collagen degradation product (β-CTX), and procollagen type 1 N-terminal propeptide (P1NP) )”, J Med Biochem, vol. 44, no. 3, pp. 587–594, Feb. 2025, doi: 10.5937/jomb0-51444.